The World Health Organisation (WHO) has suspended Anuh Pharma’s products -- Pyrazinamide and Sulfadoxine from prequalified list of active pharmaceutical ingredients (API). Pre-qualification is a process under which drug companies have to fulfil certain WHO-stipulated conditions to become eligible to supply vaccines to UN procurement agencies globally.
The WHO's move comes in the wake of European Directorate for the Quality of Medicines and Healthcare (EQDM) suspending certificate of suitability for the drug firm's three products last month after conducting an inspection of its manufacturing site at Boisar in Maharashtra.
Anuh Pharma is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company is part of the SK Group, which has evolved as a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.
